Metalloproteinases are enzymes that are active at neutral pH, that contain Zn++, and that are generally not stored within the cells. The enzymes are secreted in latent form and upon activation, are capable of degrading the extracellular matrix. Metalloproteinases comprise a multi- gene family and two members are collagenase and stromelysin. Collagenase has the singular ability to initiate the degradation of collagen, the body's most abundant structural protein while stromelysin degrades non- collagenous matrix, such as proteoglycans, laminin and fibronectin. Of interest is the fact that stromelysin shares considerable homology with transin, a rat oncogene-induced proteinase, thus supporting the hypothesis that metalloproteinases may play a role in tumor/tissue invasion. Indeed, the combination of collagenase and stromelysin permits a concerted attack on most matrix components. No where is this degradative/invasive ability more apparent than in rheumatoid arthritis. In this disease, excessive production of collagenase and stromelysin by the fibroblasts that line the joint mediates the degradation of articular cartilage and subchondral bone, resulting in severe crippling and deformity. Previously, these studies have used monolayer cultures of rabbit synovial fibroblasts as a model system to study mechanisms controlling metalloproteinase gene expression as they pertained to joint disease. Most recently, however, they have been extended to human fibroblasts and results indicate that common mechanisms controlling the expression of these enzymes may be operative throughout the body. Plans for the next grant period will extend our knowledge of collagenase and stromelysin to include a more detailed understanding of the relationship between them. Thus, the specific aims of the proposal are (1) to study mechanisms regulating transcription of the rabbit collagenase gene by characterizing the sequences responsible for the induction (by agents such as Interleukin-1, phorbol esters, heat shock) and suppression (by glucocorticoids and retinoids) of collagenase synthesis; (2) to understand the comparative roles of rabbit and human stromelysin I and II in connective tissue degradation and the mechanisms regulating their expression; (3) to understand the relationship of rat collagenase to rabbit and human collagenase; and, (4) to investigate the importance of metalloproteinase expression in normal development and in tumor invasion by developing transgenic mice which carry the rabbit collagenase gene. These studies should increase our understanding of he role of metalloproteinases in the connective tissue modeling and remodeling that occurs in both normal and disease states.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR026599-13
Application #
3155440
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1980-03-01
Project End
1994-02-28
Budget Start
1992-03-01
Budget End
1993-02-28
Support Year
13
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Brinckerhoff, Constance E (2017) Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire? J Cell Physiol 232:2674-2678
Brinckerhoff, Constance E (2016) What are the therapeutic implications of increased collagen expression in melanoma cells treated with vemurafenib? Melanoma Manag 3:5-8
Jenkins, Molly H; Croteau, Walburga; Mullins, David W et al. (2015) The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Matrix Biol 48:66-77
Whipple, Chery A (2015) Tumor talk: understanding the conversation between the tumor and its microenvironment. Cancer Cell Microenviron 2:e773
Jenkins, Molly H; Steinberg, Shannon M; Alexander, Matthew P et al. (2014) Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res 27:495-501
Whipple, C A; Brinckerhoff, C E (2014) BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity. Br J Cancer 111:1625-33
Croteau, Walburga; Jenkins, Molly H; Ye, Siying et al. (2013) Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma. J Cell Physiol 228:773-80
Schmucker, Adam C; Wright, Jason B; Cole, Michael D et al. (2012) Distal interleukin-1? (IL-1?) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression. J Biol Chem 287:1189-97
Zhou, Jing; Brinckerhoff, Constance; Lubert, Susan et al. (2011) Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors. Cancer Invest 29:599-607
Blackburn, J S; Liu, I; Coon, C I et al. (2009) A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 28:4237-48

Showing the most recent 10 out of 86 publications